GDAP1
Basic information
Region (hg38): 8:74320613-74518007
Previous symbols: [ "CMT4A" ]
Links
Phenotypes
GenCC
Source:
- autosomal dominant Charcot-Marie-Tooth disease type 2K (Supportive), mode of inheritance: AD
- Charcot-Marie-Tooth disease type 4A (Supportive), mode of inheritance: AR
- Charcot-Marie-Tooth disease axonal type 2K (Supportive), mode of inheritance: AR
- Charcot-Marie-Tooth disease recessive intermediate A (Supportive), mode of inheritance: AR
- Charcot-Marie-Tooth disease recessive intermediate A (Strong), mode of inheritance: AR
- Charcot-Marie-Tooth disease axonal type 2K (Strong), mode of inheritance: AD
- Charcot-Marie-Tooth disease (Definitive), mode of inheritance: Semidominant
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Charcot-Marie-Tooth disease, recessive intermediate, A; Charcot-Marie-Tooth disease, axonal, with vocal cord paresis; Charcot-Marie-Tooth disease, axonal, type 2K; Charcot-Marie-Tooth disease, type 4A | AD/AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 11743579; 11743580; 12499475; 12707075; 12566285; 15805163; 17039978; 18492089; 20685671; 21753178; 22200116; 22971097 |
ClinVar
This is a list of variants' phenotypes submitted to
- Charcot-Marie-Tooth disease type 4A (47 variants)
- Charcot-Marie-Tooth disease axonal type 2K (19 variants)
- Charcot-Marie-Tooth disease (16 variants)
- not provided (11 variants)
- Charcot-Marie-Tooth disease recessive intermediate A (4 variants)
- Inborn genetic diseases (3 variants)
- Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomal recessive (3 variants)
- Charcot-Marie-Tooth disease axonal type 2K;Charcot-Marie-Tooth disease recessive intermediate A;Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomal recessive;Charcot-Marie-Tooth disease type 4A (2 variants)
- GDAP1-related disorder (1 variants)
- Charcot-Marie-Tooth disease axonal type 2K;Charcot-Marie-Tooth disease type 4A;Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomal recessive;Charcot-Marie-Tooth disease recessive intermediate A (1 variants)
- Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomal recessive;Charcot-Marie-Tooth disease axonal type 2K;Charcot-Marie-Tooth disease type 4A;Charcot-Marie-Tooth disease recessive intermediate A (1 variants)
- Peripheral neuropathy (1 variants)
- Neuropathy, axonal, with vocal cord paresis, autosomal recessive (1 variants)
- Charcot-Marie-Tooth disease recessive intermediate A;Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomal recessive;Charcot-Marie-Tooth disease axonal type 2K;Charcot-Marie-Tooth disease type 4A (1 variants)
- Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomal recessive;Charcot-Marie-Tooth disease recessive intermediate A;Charcot-Marie-Tooth disease axonal type 2K;Charcot-Marie-Tooth disease type 4A (1 variants)
- Charcot-Marie-Tooth disease recessive intermediate A;Charcot-Marie-Tooth disease axonal type 2K;Charcot-Marie-Tooth disease type 4A (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GDAP1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 65 | 68 | ||||
missense | 12 | 20 | 161 | 193 | ||
nonsense | 13 | 20 | ||||
start loss | 2 | |||||
frameshift | 22 | 29 | ||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 9 | |||||
splice region | 14 | 6 | 1 | 21 | ||
non coding | 59 | 52 | 40 | 151 | ||
Total | 51 | 40 | 223 | 117 | 42 |
Highest pathogenic variant AF is 0.000151
Variants in GDAP1
This is a list of pathogenic ClinVar variants found in the GDAP1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
8-74320911-C-G | not specified | Uncertain significance (Nov 07, 2022) | ||
8-74320914-TC-T | Congenital myopathy | Likely pathogenic (Nov 17, 2023) | ||
8-74320934-G-T | Congenital myopathy | Likely pathogenic (Nov 17, 2023) | ||
8-74320979-G-A | Benign (Dec 31, 2019) | |||
8-74321066-C-T | JPH1-related disorder | Likely benign (Jul 12, 2019) | ||
8-74321166-G-C | not specified | Uncertain significance (Nov 18, 2022) | ||
8-74321269-C-T | not specified | Uncertain significance (Mar 27, 2023) | ||
8-74350062-C-A | Likely benign (Aug 14, 2018) | |||
8-74350137-A-T | Likely benign (Nov 22, 2018) | |||
8-74350205-T-TA | Benign (Nov 14, 2019) | |||
8-74350205-T-TAA | Likely benign (Nov 14, 2019) | |||
8-74350205-T-TAAA | Benign (Aug 18, 2019) | |||
8-74350205-T-TAAAA | Benign (Sep 02, 2019) | |||
8-74350276-G-A | Likely benign (Jul 26, 2019) | |||
8-74350301-G-T | Benign (Jun 14, 2018) | |||
8-74350331-A-T | Benign (Sep 29, 2018) | |||
8-74350371-CCT-C | Charcot-Marie-Tooth disease type 4A | Benign (Aug 30, 2023) | ||
8-74350409-GGGA-G | Charcot-Marie-Tooth, Intermediate • Charcot-Marie-Tooth with Vocal Cord Paresis | Benign/Likely benign (Jun 14, 2016) | ||
8-74350442-C-T | not specified | Likely benign (Dec 29, 2016) | ||
8-74350443-C-T | Charcot-Marie-Tooth disease | Likely benign (-) | ||
8-74350458-C-G | Likely benign (Mar 03, 2015) | |||
8-74350461-GA-G | Charcot-Marie-Tooth disease type 4A | Pathogenic (Jul 29, 2022) | ||
8-74350462-A-G | Charcot-Marie-Tooth disease type 4A | Pathogenic (Sep 08, 2023) | ||
8-74350462-A-T | Charcot-Marie-Tooth disease • Charcot-Marie-Tooth disease axonal type 2K | Conflicting classifications of pathogenicity (Jan 06, 2016) | ||
8-74350465-G-A | Charcot-Marie-Tooth disease | Uncertain significance (-) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GDAP1 | protein_coding | protein_coding | ENST00000220822 | 6 | 167743 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.24e-8 | 0.539 | 125696 | 0 | 52 | 125748 | 0.000207 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.00 | 150 | 189 | 0.795 | 0.0000104 | 2339 |
Missense in Polyphen | 67 | 87.536 | 0.7654 | 1046 | ||
Synonymous | -0.510 | 77 | 71.5 | 1.08 | 0.00000398 | 682 |
Loss of Function | 1.03 | 14 | 18.8 | 0.743 | 0.00000115 | 217 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000759 | 0.000759 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000217 | 0.000217 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000150 | 0.000149 |
Middle Eastern | 0.000217 | 0.000217 |
South Asian | 0.000196 | 0.000196 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Regulates the mitochondrial network by promoting mitochondrial fission. {ECO:0000269|PubMed:16172208}.;
- Disease
- DISEASE: Charcot-Marie-Tooth disease 4A (CMT4A) [MIM:214400]: A recessive demyelinating form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot- Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Demyelinating neuropathies are characterized by severely reduced nerve conduction velocities (less than 38 m/sec), segmental demyelination and remyelination with onion bulb formations on nerve biopsy, slowly progressive distal muscle atrophy and weakness, absent deep tendon reflexes, and hollow feet. By convention autosomal recessive forms of demyelinating Charcot-Marie-Tooth disease are designated CMT4. CMT4A is a severe form characterized by early age of onset and rapid progression leading to inability to walk in late childhood or adolescence. {ECO:0000269|PubMed:11743579, ECO:0000269|PubMed:12601710, ECO:0000269|PubMed:15772096, ECO:0000269|PubMed:16172208}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomal recessive (CMT2RV) [MIM:607706]: A form of Charcot-Marie-Tooth disease characterized by the association of axonal neuropathy with vocal cord paresis. Charcot-Marie-Tooth disease is a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. {ECO:0000269|PubMed:12868504, ECO:0000269|PubMed:16172208}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Charcot-Marie-Tooth disease 2K (CMT2K) [MIM:607831]: An axonal form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Neuropathies of the CMT2 group are characterized by signs of axonal degeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy. Charcot-Marie-Tooth disease type 2K onset is in early childhood (younger than 3 years). This phenotype is characterized by foot deformities, kyphoscoliosis, distal limb muscle weakness and atrophy, areflexia, and diminished sensation in the lower limbs. Weakness in the upper limbs is observed in the first decade, with clawing of the fingers. Inheritance can be autosomal dominant or recessive. {ECO:0000269|PubMed:15772096, ECO:0000269|PubMed:20685671, ECO:0000269|PubMed:22206013, ECO:0000269|PubMed:26525999, ECO:0000269|PubMed:28244113}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Charcot-Marie-Tooth disease, recessive, intermediate type, A (CMTRIA) [MIM:608340]: A form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Recessive intermediate forms of Charcot-Marie-Tooth disease are characterized by clinical and pathologic features intermediate between demyelinating and axonal peripheral neuropathies, and motor median nerve conduction velocities ranging from 25 to 45 m/sec. {ECO:0000269|PubMed:12499475, ECO:0000269|PubMed:12566285, ECO:0000269|PubMed:15772096, ECO:0000269|PubMed:16172208}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.163
Intolerance Scores
- loftool
- 0.213
- rvis_EVS
- -0.69
- rvis_percentile_EVS
- 14.97
Haploinsufficiency Scores
- pHI
- 0.174
- hipred
- N
- hipred_score
- 0.462
- ghis
- 0.652
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.808
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gdap1
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); cellular phenotype; homeostasis/metabolism phenotype;
Zebrafish Information Network
- Gene name
- gdap1
- Affected structure
- peripheral neuron
- Phenotype tag
- abnormal
- Phenotype quality
- branchiness
Gene ontology
- Biological process
- mitochondrial fission;protein targeting to mitochondrion;mitochondrion organization;mitochondrial fusion;response to retinoic acid;cellular response to vitamin D
- Cellular component
- nucleus;mitochondrion;cytosol;membrane;integral component of mitochondrial outer membrane
- Molecular function